Plasmodium falciparum normocyte binding protein (PfNBP-1) peptides bind specifically to human erythrocytes

John Jairo Valbuena1, Ricardo Vera, Javier García

  • 1Fundación Instituto de Inmunología de Colombia, Universidad Nacional de Colombia, Cra 50 26-00, Bogotá, Colombia. john_valbuena@fidic.org.co

Peptides
|September 23, 2003
PubMed

Insights

Plasmodium falciparum normocyte binding protein-1 (PfNBP-1) binds to human red blood cells. Specific peptides of PfNBP-1 block malaria parasite invasion, offering potential therapeutic targets.

Area of Science:

  • Malariology
  • Molecular Parasitology
  • Structural Biology

Background:

  • Plasmodium falciparum normocyte binding protein-1 (PfNBP-1) is a Plasmodium vivax RBP-1 orthologue.
  • PfNBP-1 is localized to the apical merozoite region.
  • PfNBP-1 mediates direct binding to the human erythrocyte membrane.

Purpose of the Study:

  • To identify specific regions of PfNBP-1 responsible for erythrocyte binding.
  • To characterize the binding affinity and kinetics of identified PfNBP-1 peptides.
  • To assess the inhibitory potential of PfNBP-1 peptides on malaria parasite invasion.

Main Methods:

  • Erythrocyte binding assays using synthetic peptides derived from PfNBP-1.
  • Determination of binding affinity and saturation kinetics.
  • Competition assays with glycine-scan analogue peptides to identify critical binding residues.

Main Results:

  • Two high-affinity erythrocyte binding peptides (26332 and 26336) were identified within PfNBP-1.
  • These peptides exhibited saturable binding with nanomolar affinity constants.
  • Critical binding residues were pinpointed, and these peptides successfully blocked in vitro merozoite invasion of erythrocytes.

Conclusions:

  • Specific peptide sequences within PfNBP-1 are crucial for erythrocyte binding.
  • These identified peptides demonstrate potential as inhibitors of Plasmodium falciparum invasion.
  • PfNBP-1 and its binding domains represent promising targets for antimalarial drug development.